A Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa

Welcome, Introduction, and Baseline Assessment

Spotting HS: Clinical Presentation, Diagnosis, and Pathogenesis

• HS phenotypes, typical lesions and locations
• Implications of delayed diagnosis
• Consensus-driven clinical diagnostic criteria
• Risk factors for developing HS
• Key cytokines driving HS inflammation/progression
• Master Class interactive case discussions

Advances in HS Management

• Approved targeted therapies:
• Emerging therapies
• Selecting patient candidates
• Master class interactive case discussions

Patient-Centered Care and Long-term Management in HS

• QoL considerations
• Addressing comorbidities
• Patient education
• Addressing barriers to health equity
• Master Class interactive case discussions

Key Takeaways and Posteducation Assessment

Goal
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize the identification and management of patients with hidradenitis suppurativa.

Target Audience
This activity is intended for dermatologists, dermatology residents and fellows, nurse practitioners, and physician associates and other HCPs who care for patients with hidradenitis suppurativa.

Learning Objectives
Upon completion of this activity, participants should be able to:

• Apply consensus-driven diagnostic strategies to enhance the accuracy and timeliness of HS diagnosis

• Examine key elements of HS pathophysiology, including how they contribute to disease progression and the therapeutic rationale for targeting them with novel and emerging agents

• Assess available and emerging targeted therapies for HS according to clinical profile, safety, and efficacy

• Formulate comprehensive care plans that consider QoL and comorbidities for patients with HS, including those with skin of color